For the quarter ending 2025-09-30, HURA has $25,697,048 in assets. $8,919,089 in debts. $2,697,416 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 2,697,416 | 8,512,824 | ||
| Stock subsciption receivable | - | 2,997,547 | ||
| Other current assets | 806,429 | 1,029,088 | ||
| Total current assets | 3,503,845 | 12,539,459 | ||
| Property plant and equipment gross | 2,431,500 | - | ||
| Less accumulated depreciation and amortization | 2,136,168 | - | ||
| Property and equipment, net | 295,332 | 144,171 | ||
| Operating right-of-use assets | 82,707 | 122,511 | ||
| Goodwill | 13,554,164 | 13,554,163 | ||
| In-process research and development | 8,261,000 | 8,261,000 | ||
| Total assets | 25,697,048 | 34,621,304 | ||
| Accounts payable and accrued expenses | 5,480,577 | 12,093,163 | ||
| Note payable to former kineta employees | 493,386 | 434,000 | ||
| Holdback liability, payable in shares | 2,775,795 | 2,519,644 | ||
| Lease liabilities, current | 84,346 | 124,969 | ||
| Total current liabilities | 8,834,104 | 15,171,776 | ||
| Other long-term liabilities | 84,985 | - | ||
| Total liabilities | 8,919,089 | 15,171,776 | ||
| Preferred stock-Series APreferred Stock | 278,530 | 278,530 | ||
| Common stock, 0.001 par value, 200,000,000 and 75,000,000 shares authorized 51,254,789 and 42,323,759 shares issued and outstanding as of september 30, 2025 and december 31, 2024 | 51,255 | 49,913 | ||
| Additional paid-in capital | 150,869,671 | 146,438,038 | ||
| Accumulated deficit | -134,421,497 | -127,316,953 | ||
| Total stockholders' equity | 16,777,959 | 19,449,528 | ||
| Total liabilities and stockholders' equity | 25,697,048 | 34,621,304 | ||
TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)